Clinical relevance of determination of neutrophil gelatinase-associated lipocalin-2 in children with acute kidney injury


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Improvement of methods for diagnosis and prediction of acute kidney injury is associated with the identification and evaluation of new biomarkers associated with early stage acute kidney injury and independent of the filtration renal function. The article presents data on the evaluation of the role of neutrophil gelatinase-associated lipocalin in the diagnosis of acute kidney injury. The results of a number of studies that demonstrate the reliable efficacy of NGAL as a biomarker for predicting the risk of developing acute kidney injury and renal tubular damage are analyzed. Detection of NGAL in the urine and blood can reflect the active damage of the renal tubules, predict a decrease in the glomerular filtration rate and, thereby, predetermine the progression of the disease. It has been established that blood and urine NGAL levels is a prognostically significant biomarker of the course of acute kidney damage of different etiology in both children and adults.

Full Text

Restricted Access

About the authors

A. V Eremeeva

FSAEI HE «First Moscow State Medical University N.A. I.M. Sechenov» of RMH

PhD in Medical Science, Associate Professor at the Department of Pediatrics and Children’s Infectious Diseases

V. V Dlin

SAB «Scientific Research Clinical Institute of Pediatrics N.A. Academician Yu.E. Veltischev» FSBEI HE «Russian National Scientific Medical University N.A. N.I. Pirogov» of RMH

Email: vvdlin@mail.ru
Doctor of Medical Sciences, Professor, Deputy Director for Scientific Work

A. A Korsunsky

FSAEI HE «First Moscow State Medical University N.A. I.M. Sechenov» of RMH

Email: dr_kaa@mail.ru
Doctor of Medical Sciences, Professor, Head of the Department of Pediatrics and Children’s Infectious Diseases

N. M Zaikova

FSAEI HE «First Moscow State Medical University N.A. I.M. Sechenov» of RMH

Email: nataliazaikova@mail.ru
PhD in Medical Science, Teaching Assistant at the Department of Pediatrics and Children’s Infectious Diseases

E. D Bondarenko

FSAEI HE «First Moscow State Medical University N.A. I.M. Sechenov» of RMH

Email: alenkabond@gmail.com
Teaching Assistant at the Department of Pediatrics and Children’s Infectious Diseases

E. V Kondrikova

FSAEI HE «First Moscow State Medical University N.A. I.M. Sechenov» of RMH

Email: e.kondrikova@mail.ru
PhD in Medical Science, Associate Professor at the Department of Pediatrics and Children’s Infectious Diseases

References

  1. Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 1993;268:10425-10432.
  2. Martenson J., Bellomo R. The rise and fall of NGAL in acute kidney injury. Blood Purif. 2014;37:304-310.
  3. Hraba-Renevey S., Türler H., Kress M., Salomon C., Weil R. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene. 1989;4:601-608.
  4. Matthaeus T., Schulze-Lohoff E., Ichimura T. Co-regulation of neutrophil gelatinase- associated lipocalin and matrix metalloproteinase-9 in the post ischemic rat kidney. J. Am. Soc. Nephrol. 2001;12:787A.
  5. Mishra J., Mori K., Ma Q., Kelly C., Barasch J., Devarajan P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am. J. Nephrol. 2004;24:307-315.
  6. Schmidt-Ott K.M., Mori K., Kalandadze A., Li J.Y., Paragas N., Nicholas T., Devarajan P., Barasch J. Neutrophil gelatinaseassociated lipocalin-mediated iron traffic in kidney epithelia. Curr. Opin. Nephrol. Hypertens. 2006; 15:442-449.
  7. Cowland J.B., Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics. 1997;45:17-23.
  8. Meldrum K.K., Hile K., Meldrum D.R., Crone J.A., Gearhart J.P., Burnett A.L. Simulated ischemia induced renal tubular cell apoptosis through a nuclear factor-xB dependent mechanism. J. Urol. 2002;168:248-252.
  9. Hanai J., Mammoto T., Seth P., Mori K., Karumanchi S.A., Barasch J., Sukhatme V.P. Lipocalin 2 diminishes invasiveness and metastasis of Rastransformed cells. J. Biol. Chem. 2005;280:13641-13647.
  10. Waikar S.S., Liu K.D., Chertow G.M. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin. J. Am. Soc. Nephrol. 2008;3(3):844-861.
  11. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury // Kidney Int. Suppl. 2012. Vol. 2.
  12. Колесников С.В., Борисов А.С. Биомаркеры острого почечного повреждения: клинические аспекты. Обзор литературы. Нефрология и диализ. 2013;15(3):184-190.
  13. Malyszko J., Malyszko J.S., Koc-Zorawska E., Kozminski P., Mysliwiec M. Neutrophil Gelatinase-Associated Lipocalin in Dialyzed Patients Is Related to Residual Renal Function, Type of Renal Replacement Therapy and Inflammation. Kidney Blood Press. Res. 2010;32(6):464-469.
  14. Hall I.E., Yarlagadda S.G., Coca S.G., Wang Z., Doshi M., Devarajan P., Han W.K., Marcus R.J., Parikh C.R. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J. Am. Soc. Nephrol. 2010;21:189-197.
  15. Han W., Wagener G., Zhu Y., Wang S., Lee H.T. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery// Clinn.J. Am Soc. Nephrol. 2009;4(5):873-882.
  16. Endre Z.H., Pickering J.W., Walker R.J., Devarajan P., Edelstein C.L., Bonventre J.V., Frampton C.M., Bennett M.R., Ma Q., Sabbisetti V.S., Vaidya V.S., Walcher A.M., Shaw G.M., Henderson S.J., Nejat M., Scholium J.B., George P.M. Improved performance of urinary biomarkers of acute kidney injury biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function//Kidney Int. 2011; 79(10):1119-1130.
  17. Колесников С.В., Борисов А.С. Сравнительная оценка мочевого NGAL и периоперационных факторов в прогнозировании неблагоприятных исходов острого почечного повреждения у кардиохирургических больных пожилого возраста. Нефрология и диализ. 2013;15(3):184-190.
  18. Mishra J., Ma Q., Kelly C., Mitsnefes M., Mori K., Barasch J., Devarajan P. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr. Nephrol. 2006;21856-21863.
  19. Mori K., Lee H.T., Rapoport D. Drexler I.R., Foster K., Yang J., Schmidt-Ott K.M., Chen X., Li J.Y., Weiss S., Mishra J., Cheema F.H., Markowitz G., Suganami T., Sawai K., Mukoyama M., Kunis C., D’Agati V., Devarajan P., Barasch J. Endocytic delivery of lipocalin-siderophoreiron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 2005;115:610-621.
  20. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 2009; 54:1012-1024.
  21. Xu S.Y., Pauksen K., Venge P. Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand. J. Clin. Lab. Invest. 1995;55:125-131.
  22. Fjaertoft G., Foucard T., Xu S., Venge P. Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: A study of the kinetics. Acta. Paediatr. 2005;94:661- 666.
  23. Ryon J., Bendickson L., Nilsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem. J. 2002;367:271-277.
  24. Flo T.H., Smith K.D., Sato S, Rodriguez D.J., Holmes M.A., Strong R.K., Akira S., Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432:917-921.
  25. Uttenthal L.O. NGAL: a marker molecule for the distressed kidney? Clinical Laboratory international, 2005.
  26. Trachtman H., Christen E., Cnaan A., Gibbs K., Zhao S., Acheson D.W., Weiss R., Kaskel F.J., Spitzer A., Hirschman G.H. Investigators of the HUSSYNSORB Pk Multicenter Clinical Trial. Urinary neutrophil gelatinase-associated lipocalin in D+HUS: a novel marker of renal injury. Pediatr. Nephrol. 2006 21:989-994.
  27. Haase-Fielitz A., Bellomo R., Devarajan P., Bennett M., Story D., Matalanis G., Frei U., Dragun D., Haase M. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol. Dial. Transplant. 2009;11(24);3349-3354.
  28. Brunner H.I., Mueller M., Rutherford C., Passo M.H., Witte D., Grom A., Mishra J., Devarajan P. Urinary NGAL as a biomarker of nephritis in childhood-onset SLE. Arthritis Rheum. 2006;54:2577-2584.
  29. Lebkowska U., Malyszko J., Lebkowska A., Koc-Zorawska E., Lebkowski W., Malyszko J.S., Kowalewski R., Gacko M. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study. Transplant. Proc. 2009;41:154-157.
  30. Hall I.E., Doshi M.D., Reese P.P., Marcus R.J., Thiessen-Philbrook H., Parikh C.R. Association between peritransplant kidney injury biomarkers and 1- year allograft outcomes. Clinical Journal of the American Society of Nephrology. 2012;7(8):1224-1233.
  31. Ojo A.O., Wolfe R.A., Held P.J., Port F.K., Schmouder R.L. Delayed graft function: risk factors and implications for renal allograft survival. Transplantat ion1997;63(7):968-974.
  32. Makris K., Markou N., Evodia E., Dimopoulou E., Drakopoulos I., Ntetsika K., Rizos D., Baltopoulos G., Haliassos A. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin. Chem. Lab. Med. 2009;47(1):79-82.
  33. Rosner M.H., Okusa M.D. Acute kidney injury associated with cardiac surgery. Clin. J. Am. Soc. Nephrol. 2006;1(1):19-32.
  34. Koyner J.L., Bennett M.R., Worcester E.M., Ma Q., Raman J., Jeevanandam V., Kasza K.E., O’Connor M.F., Konczal D.J., Trevino S., Devarajan P., Murray P.T. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74(8): 1059-1069.
  35. Wasilewska A., Zoch-Zwierz W., Taranta-Janusz K., Michaluk-Skutnik J. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr. Nephrol. 2010;25(5):889-897.
  36. Devarajan P. Neutrophil gelatinase-associated lipocalinan emerging troponin for kidney injury. Nephrol. Dial. Transplant. 2008,23:3737-3743.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies